TrialClinical pharmacokinetics2015

Pharmacokinetics of Sublingual Buprenorphine and Naloxone in Subjects with Mild to Severe Hepatic Impairment (Child-Pugh Classes A, B, and C), in Hepatitis C Virus-Seropositive Subjects, and in Healthy Volunteers.

Azmi F Nasser et al.PubMed ↗Publisher ↗

No numbers read from the abstract.